u 74006f has been researched along with Parkinson Disease, Secondary in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Brundin, P; Gidö, G; Karlsson, J; Petersén, A; Wieloch, T | 1 |
| Earl, CD; Höglinger, GU; Oertel, WH; Sautter, J | 1 |
2 other study(ies) available for u 74006f and Parkinson Disease, Secondary
| Article | Year |
|---|---|
Combining neuroprotective treatment of embryonic nigral donor tissue with mild hypothermia of the graft recipient.
Topics: Amino Acid Chloromethyl Ketones; Animals; Caspase Inhibitors; Cell Count; Cell Transplantation; Female; Graft Survival; Hypothermia, Induced; Mesencephalon; Neurons; Neuroprotective Agents; Parkinson Disease, Secondary; Pregnatrienes; Rats; Rats, Sprague-Dawley; Transplantation, Heterologous | 2005 |
Systemic treatment with GM1 ganglioside improves survival and function of cryopreserved embryonic midbrain grafted to the 6-hydroxydopamine-lesioned rat striatum.
Topics: Animals; Brain Tissue Transplantation; Cell Count; Cell Survival; Corpus Striatum; Cryopreservation; Disease Models, Animal; Female; Fetal Tissue Transplantation; G(M1) Ganglioside; Graft Survival; Mesencephalon; Motor Activity; Neurons; Neuroprotective Agents; Oxidopamine; Parkinson Disease, Secondary; Pregnatrienes; Rats; Rats, Sprague-Dawley; Recovery of Function; Tyrosine 3-Monooxygenase | 2000 |